cbdMD Files New Patent Application to Advance Its Strategy to Broaden Intellectual Property Portfolio
July 13 2020 - 8:00AM
Business Wire
Patent Application Seeks Patent Protection for
a Wide Range of Novel CBD Technologies and Methods
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A), one of the
leading, most trusted and most recognized cannabidiol (CBD)
consumer brands, announced today that it has filed a new patent
application with the U.S. Patent and Trademark Office which will
allow it to pursue patented protection in several key areas,
including novel formulations and delivery systems, as well as
methods of manufacturing and use. The recent submission by the
company is part of its ongoing intellectual property strategy to
ensure appropriate protection around its product lines and to be
forward-thinking as to the direction of the CBD market.
“cbdMD has always been a leader of innovation the CBD industry.
Pursuing intellectual property will remain a priority for us as we
continue to strengthen and grow the company’s assets within a
fiscally disciplined mindset,” said Martin A. Sumichrast, Chairman
and co-CEO at cbdMD, Inc. “The filing of this new patent
application furthers supports our mission of being a preeminent
science-based company in a currently congested CBD marketplace.
Continued research and development for real world applications
drives innovation and protecting those proprietary technologies and
ideas is consistent with cbdMD’s business plan. We look forward to
our future innovation and continuing to pursue additional IP
protection.”
About cbdMD
cbdMD, Inc. is one of the leading, most trusted and most
recognized cannabidiol (CBD) consumer brands, whose current
products include CBD tinctures, CBD capsules, CBD gummies, CBD
topicals, CBD bath bombs and CBD pet products. cbdMD is also a
proud partner of Bellator MMA and Life Time, Inc., and has one of
the largest rosters of professional sports athletes who are part of
“Team cbdMD.” To learn more about cbdMD and our comprehensive line
of over 100 SKUs of U.S. produced, THC-free1 CBD products, please
visit www.cbdMD.com, follow cbdMD on
Instagram and Facebook, or visit one of the 6,000 retail outlets
that carry cbdMD products.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. The words "believe," "may," "estimate," "continue,"
"anticipate," "intend," "should," "plan," "could," "target,"
"potential," "is likely," "will," "expect" and similar expressions,
as they relate to us, are intended to identify forward-looking
statements. cbdMD, Inc. has based these forward-looking statements
largely on our current expectations and projections about our
ability to protect our intellectual property, the granting of the
patent by the U.S. Patent and Trademark Office, and future events
and financial trends that we believe may affect our financial
condition, results of operations, business strategy and financial
needs. Some or all of the results anticipated by these
forward-looking statements are unknown at this time. Further
information on cbdMD’s risk factors is contained in Annual Report
on Form 10-K for the year ended September 30, 2019, as amended,
Part II, Item 1A. Risk Factors appearing in our Quarterly Report on
Form 10-Q for the period ended March 31, 2020, and our other
filings with the Securities and Exchange Commission. Any
forward-looking statement made by us herein speaks only as of the
date on which it is made. Factors or events that could cause our
actual results to differ may emerge from time to time, and it is
not possible for us to predict all of them. cbdMD, Inc. undertakes
no obligation to publicly update any forward-looking statement,
whether as a result of new information, future developments or
otherwise, except as may be required by law. The information which
appears on our websites and our social media platforms, including,
but not limited to, Instagram and Facebook, is not part of this
press release.
1THC-free is defined as undetectable at the lowest level which
can be consistently detected using valid scientific analytical
tools.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200713005150/en/
PR: cbdMD, Inc. Lauren Greene, 843-743-9999
Lauren.greene@cbdmd.com
Investors: cbdMD, Inc. John Weston, 704-445-3060 ext. 1103
john.weston@cbdmd.com
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Aug 2024 to Sep 2024
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Sep 2023 to Sep 2024